Back to results
US 2023/0414730 A1Published application
A composition comprising extra-cellular vesicles from mesenchymal stem cells and alpha-1 antitrypsin for the treatment of viral infections
AssigneeAatec Medical GmbH
InventorsManfred Stangl, Michael Strassmair
Life of this patent
Estimating the term…
Abstract
A method for treating and/or reducing the risk of a viral infection in a human subject, including administering a pharmaceutical composition including Alpha-1 antitrypsin (AAT) protein to a subject in need thereof, wherein the composition is administered by inhalation.
Claims18
A method for treating and/or reducing the risk of a viral infection in a human subject, comprising administering a pharmaceutical composition comprising Alpha-1 antitrypsin (AAT) protein to a subject in need thereof, wherein the composition is administered by inhalation.
The method, wherein the composition is in the form of a dry powder.
Dependencies are inferred from the claim text.